Arcadia Biosciences Inc reports results for the quarter ended September 30 - Earnings Summary
13/11/2024 24:08
* Arcadia Biosciences Inc RKDA.OQ reported a quarterly
adjusted
loss of $1.18 per share for the quarter ended September 30,
higher than the same quarter last year, when the company
reported EPS of $-1.44. The mean expectation of two analysts
for the quarter was for a loss of 81 cents per share. Wall
Street expected results to range from -85 cents to -77 cents per
share.
* Revenue fell 3.8% to $1.54 million from a year ago;
analysts
expected $1.40 million.
* Arcadia Biosciences Inc's reported EPS for the quarter was
a
loss of $1.18.
* The company reported a quarterly loss of $1.61 million.
* Arcadia Biosciences Inc shares had risen by 55.3% this
quarter and gained 35.5% so far this year.
FORECAST CHANGES
* The mean earnings estimate of analysts had risen by
about 13.8%
in the last three months.
* In the last 30 days, there have been no earnings estimate
revisions by analysts covering the company.
RECOMMENDATIONS
* The current average analyst rating on the shares is "buy"
and
the breakdown of recommendations is 2 "strong buy" or "buy," no
"hold" and no "sell" or "strong sell."
* The average consensus recommendation for the food
processing
peer group is also "buy"
Wall Street's median 12-month price target for Arcadia
Biosciences Inc is 9.00
This summary was machine generated from LSEG data November 13 at
12:08 a.m. UTC. All figures in US dollars unless otherwise
stated. (For questions concerning the data in this report,
contact Estimates.Support@lseg.com. For any other questions or
feedback, contact RefinitivNewsSupport@thomsonreuters.com) QUARTER ENDING ESTIMATE ACTUAL BEAT, MET,
MISSED
Sep. 30 2024 -1.18
Jun. 30 2024 1.55 0.78 Missed
Mar. 31 2024 -2.21 -1.78 Beat
Dec. 31 2023 -2.58 -2.52 Beat